- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in gsk
Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could begin by April
Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could begin by April
Read MoreGSK Consumer Forays Into Nasal Wash Segment
A saline wash with the moisturising benefit of natural glycerin, the product comes with strong safety cues and is recommended for daily usage, the company said in a statement.
Read MoreSanofi And GSK Delay COVID-19 Vaccine, Marking Setback To Global Fight
Sanofi is also working on another vaccine candidate to prevent COVID-19 with U.S. company Translate Bio which will rely on a different technology called mRNA, similar to the developed by Pfizer and Moderna.
Read MoreRussia's Sputnik V developers ready to share technology with Sanofi / GSK amid vaccine delay
Russia's Sputnik V developers ready to share technology with Sanofi / GSK amid vaccine delay
Read MoreGSK, Sanofi To Make 200 Million Doses Available For COVID-19 Vaccine Alliance
GSK-Sanofi has currently signed a $2.1 billion deal with the U.S. to supply it with more than 100 million doses of its coronavirus vaccine candidate. The companies also have deals with the European Union and UK.
Read MoreSanofi, GSK Launch Trial For COVID-19 Protein-Based Vaccine
Sanofi and GSK said on Thursday that they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which they hope to make available across the world.
Read More